United States · FDA National Drug Code directory
Nateglinide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72241-003_af81465b-5f49-4eeb-8122-ef7fe5d90ddc
- Product NDC
- 72241-003
- Form
- TABLET, COATED
- Composition / generic term
- Nateglinide
- Labeler
- Modavar Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210819
- Source listing expiry
- 20261231
Source-listed ingredients
- NATEGLINIDE — 120 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET, COATED in 1 BOTTLE (72241-003-04) · 72241-003-04
- 100 TABLET, COATED in 1 BOTTLE (72241-003-05) · 72241-003-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →